In this piece, we explore reasons for creating a separate conversion factor within the MPFS, initially for advanced primary ...
Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease, announced today that ...
NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company focused on transforming the lives of people living with epilepsy ...
New OPPS and PFS reimbursement rates give hospitals, imaging centers and physicians a unified path to use AI plaque analysis starting 2026 STAMFORD, Conn., Nov. 25, 2025 /PRNewswire/ -- Caristo ...
LUND, Sweden - Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a national payment ...
After issuing the Physician Fee Schedule (PFS) on October 31, the Centers for Medicare & Medicaid Services (CMS) has now published templates ...
US Medicare Sets Reimbursement Price For Promarkerd DKD Test. Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce that the U ...
Devyser today announced that the Centers for Medicare & Medicaid Services (CMS) has issued its final pricing determination for the company's PrenatalDetect RHD test (CPT 0536U) at $192. The non-invasi ...
On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule (PFS) final rule for calendar year (CY) ...
Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare & Medicaid Services (CMS) on its Calendar Year 2026 Medicare ...
MedPage Today on MSN
Medicare Rule on Outpatient, Ambulatory Surgical Center Rates Gets Divided Reactions
Hospital groups and patient advocacy organizations clashed over potential benefits and harms of the latest Medicare payment policies and rates for hospital outpatient and ambulatory surgical center ...
(GLOBE NEWSWIRE) -- (OTC: BSEM), a leading MedTech company specializing in placental-derived biologics for advanced wound care, today commented on the Centers for Medicare & Medicaid Services’ (“CMS” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results